OBJECTIVE: Animal models suggest that the development of psychosis involves hyperactivity in the hippocampus that drives increased activity in the midbrain and basal ganglia. The authors examined this hypothesis by measuring resting perfusion in the hippocampus, basal ganglia, and midbrain in people at high risk of psychosis. METHOD: Pseudo-continuous arterial spin labeling imaging was used to measure resting regional cerebral blood flow (rCBF) in 52 individuals at ultra-high risk for psychosis and in 27 healthy volunteers. The severity of psychotic symptoms was assessed using the Comprehensive Assessment of At-Risk Mental States. The ultra-high-risk subjects were reassessed after a mean of 17 months, using the same measures as at baseline. RESULTS: At baseline, relative to healthy volunteers, ultra-high-risk subjects showed elevated rCBF in the hippocampus, basal ganglia, and midbrain. In the ultra-high-risk sample overall, at follow-up, symptomatic improvement and reduced rCBF in the hippocampus and ventral striatum were observed. Subjects whose symptoms had resolved such that they no longer met ultra-high-risk criteria showed a longitudinal reduction in left hippocampal rCBF that was not evident in subjects who remained in a high-risk state or had become psychotic. CONCLUSIONS: A high risk for psychosis was associated with increased resting activity in the hippocampus, midbrain, and basal ganglia. Subsequent resolution of the high-risk state was linked to a normalization of activity in these regions. These findings are consistent with animal models that propose that psychotic symptoms may be generated when hippocampal hyperactivity drives hyperactivity in regions involved in subcortical dopamine signaling.
OBJECTIVE: Animal models suggest that the development of psychosis involves hyperactivity in the hippocampus that drives increased activity in the midbrain and basal ganglia. The authors examined this hypothesis by measuring resting perfusion in the hippocampus, basal ganglia, and midbrain in people at high risk of psychosis. METHOD: Pseudo-continuous arterial spin labeling imaging was used to measure resting regional cerebral blood flow (rCBF) in 52 individuals at ultra-high risk for psychosis and in 27 healthy volunteers. The severity of psychotic symptoms was assessed using the Comprehensive Assessment of At-Risk Mental States. The ultra-high-risk subjects were reassessed after a mean of 17 months, using the same measures as at baseline. RESULTS: At baseline, relative to healthy volunteers, ultra-high-risk subjects showed elevated rCBF in the hippocampus, basal ganglia, and midbrain. In the ultra-high-risk sample overall, at follow-up, symptomatic improvement and reduced rCBF in the hippocampus and ventral striatum were observed. Subjects whose symptoms had resolved such that they no longer met ultra-high-risk criteria showed a longitudinal reduction in left hippocampal rCBF that was not evident in subjects who remained in a high-risk state or had become psychotic. CONCLUSIONS: A high risk for psychosis was associated with increased resting activity in the hippocampus, midbrain, and basal ganglia. Subsequent resolution of the high-risk state was linked to a normalization of activity in these regions. These findings are consistent with animal models that propose that psychotic symptoms may be generated when hippocampal hyperactivity drives hyperactivity in regions involved in subcortical dopamine signaling.
Authors: Karoline Schneider; Lars Michels; Matthias N Hartmann-Riemer; Achim Burrer; Philippe N Tobler; Philipp Stämpfli; Matthias Kirschner; Erich Seifritz; Stefan Kaiser Journal: J Psychiatry Neurosci Date: 2019-03-01 Impact factor: 6.186
Authors: Christian S Legind; Brian V Broberg; Rachel Brouwer; René C W Mandl; Bjørn H Ebdrup; Simon J Anhøj; Maria H Jensen; Rikke Hilker; Birgitte Fagerlund; Hilleke E Hulshoff Pol; Birte Y Glenthøj; Egill Rostrup Journal: Schizophr Bull Date: 2019-10-24 Impact factor: 9.306
Authors: Rick P F Wolthusen; Garth Coombs; Emily A Boeke; Stefan Ehrlich; Stephanie N DeCross; Shahin Nasr; Daphne J Holt Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-07-13
Authors: Paulo L Lizano; Jeffrey K Yao; Neeraj Tandon; Suraj Sarvode Mothi; Debra M Montrose; Matcheri S Keshavan Journal: Schizophr Res Date: 2016-11-15 Impact factor: 4.939
Authors: Paul Allen; Matilda Azis; Gemma Modinos; Matthijs G Bossong; Ilaria Bonoldi; Carly Samson; Beverly Quinn; Matthew J Kempton; Oliver D Howes; James M Stone; Maria Calem; Jesus Perez; Sagnik Bhattacharayya; Matthew R Broome; Anthony A Grace; Fernando Zelaya; Philip McGuire Journal: Schizophr Bull Date: 2018-10-17 Impact factor: 9.306
Authors: Gemma Modinos; Paul Allen; Andre Zugman; Danai Dima; Matilda Azis; Carly Samson; Ilaria Bonoldi; Beverly Quinn; George W G Gifford; Sophie E Smart; Mathilde Antoniades; Matthijs G Bossong; Matthew R Broome; Jesus Perez; Oliver D Howes; James M Stone; Anthony A Grace; Philip McGuire Journal: Schizophr Bull Date: 2020-04-10 Impact factor: 9.306